Oncotarget

Reviews:

TLE1 function and therapeutic potential in cancer

Da Yuan, Xue Yang, Zhenpeng Yuan, Yanqing Zhao and Junchao Guo _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:15971-15976. https://doi.org/10.18632/oncotarget.13278

Metrics: PDF 2013 views  |   HTML 2919 views  |   ?  


Abstract

Da Yuan1,*, Xue Yang2,*, Zhenpeng Yuan3, Yanqing Zhao4 and Junchao Guo1

1 Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2 Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

3 Department of Pediatric Cardiac Surgery, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

4 Institute of Medical Information, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China

* These authors have contributed equally to this work

Correspondence to:

Junchao Guo, email:

Keywords: transducin-like enhancer of split 1; tumor; pancreatic cancer

Received: June 13, 2016 Accepted: November 01, 2016 Published: November 10, 2016

Abstract

Groucho (Gro)/Transducin-like enhancer of split (TLE) family proteins act as co-repressors of many transcription factors, and are involved in key signaling pathways. TLE1 negatively regulates inflammation and has potential roles in various diseases, including cancer. Previous studies suggest TLE1 could be used as a diagnostic marker and is a possible therapeutic target in various malignancies. It is therefore important to elucidate the mechanisms underlying TLE1 function during cancer initiation and metastasis. In this review, we highlight the functions of TLE1 in cancer and explore targeted approaches for cancer diagnosis and treatment. In particular, we discuss the TLE1 function in pancreatic cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13278